A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

NCT06906380 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia, in Relapse
Acute Myeloid Leukemia, in Relapsed or Refractory
MDS (Myelodysplastic Syndrome)

Interventions

OTHER: Non interventional study

Sponsor

ARCE Therapeutics, Inc.